CHIRON

Chiron Biotech is a Netherlands-based startup in the biotechnology industry, specializing in innovative products and solutions for the biomedical sector, regenerative medicine, and drug delivery. The company, founded in 2021, operates as a consortium comprising Concr3de BV, IPC (Innovative Polymer Comounds), the department of Biofabrication of UMCUtrecht, and the department of Biofabrication of the Trinity College of Dublin.

Chiron's main focus revolves around the creation and validation of a bio-inkjet platform, encompassing 3D bioprinters and biomaterials tailored for both research and clinical applications. Their platform aims to enable the precise patterning of a diverse portfolio of biomaterials, matrices, and cells with high spatiotemporal resolution, initially demonstrated through osteochondral tissue cases. As a trailblazer in the field, Chiron is set to become the first 3D bio-inkjet platform capable of swiftly and accurately generating a wide range of complex biomimetic tissue micro- and macro-environments.

Despite the lack of publicly available last investment and last investment investors data, Chiron Biotech's innovative approach and the esteemed consortium backing the startup position it as a promising venture for potential investors seeking involvement in advanced biomedical technologies with groundbreaking potential.